Dr. Michael Robert Dorwart, MD

Dr. Dorwart practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Dorwart's NPI, 1225243892, was assigned on May 14, 2007. Dr. Dorwart graduated from Indiana University School of Medicine in 2006. Dr. Dorwart holds Indiana license 01064446A.

Dr. Dorwart's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Dorwart's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dr. Dorwart is also affiliated with Hendricks Regional Health Danville Hospital. The medical group on file is IU Health Physicians. Dmand AI also links Dr. Dorwart to 1 more behavioral health center, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dorwart practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Dorwart's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dr. Dorwart is licensed in Indiana.

CMS data shows 939 Medicare services from Dr. Dorwart across 9 procedure codes in 2024, for 241 Medicare patients. Medicare paid $58,330 for them.

CMS counts 241 Medicare patients who saw Dr. Dorwart in 2024. The largest group is 65 to 74, with 85 patients. 75% of them have arthritis, and 75% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dorwart's median patient age at 62, with 65% women.

In 2024, Dr. Dorwart wrote 3,014 Medicare Part D claims for 420 patients. 92% of them were for generic drugs. CMS names the drug for 2,886 of them, across 34 drugs with 11 or more claims each, at $95,174 in total drug cost. In 2023, CMS named 2,929 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 36 out of 100 for Dr. Dorwart for performance year 2024, reported individually. Dr. Dorwart accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Dorwart, published from 2016 to 2024. 2016 was the busiest year, with 2. The most frequent topics are Equipment Design, Nanopores and Nucleotides. Dr. Dorwart has published most often in Proc Natl Acad Sci U S A. Dr. Dorwart's most frequent co-authors are Alexander Hsin-Chih Yang, MD, Melissa K. Cavaghan, MD and Gary Cohen, MD.

CMS Open Payments shows 177 general payments to Dr. Dorwart from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Medtronic USA, Inc. paid the most, $2,020.

Dr. Dorwart graduated from Indiana University School of Medicine in 2006.